相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Art of Making Artificial Liver: Depicting Human Liver Biology and Diseases in Mice
Go Sugahara et al.
SEMINARS IN LIVER DISEASE (2020)
Culture density contributes to hepatic functions of fresh human hepatocytes isolated from chimeric mice with humanized livers: Novel, long-term, functional two-dimensionalin vitrotool for developing new drugs
Chihiro Yamasaki et al.
PLOS ONE (2020)
Efficient in vivo editing of OTC-deficient patient-derived primary human hepatocytes
Samantha L. Ginn et al.
JHEP REPORTS (2020)
Prediction of Human Hepatic Clearance for Cytochrome P450 Substrates via a New Culture Method Using the Collagen Vitrigel Membrane Chamber and Fresh Hepatocytes Isolated from Liver Humanized Mice
Ryuji Watari et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
A liver-humanized mouse model of carbamoyl phosphate synthetase 1-deficiency
Raghuraman C. Srinivasan et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2019)
Metabolism of Butyrylfentanyl in Fresh Human Hepatocytes: Chemical Synthesis of Authentic Metabolite Standards for Definitive Identification
Tatsuyuki Kanamori et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
A randomized trial to study the comparative efficacy of phenylbutyrate and benzoate on nitrogen excretion and ureagenesis in healthy volunteers
Sandesh C. S. Nagamani et al.
GENETICS IN MEDICINE (2018)
Use of hepatocytes isolated from a liver-humanized mouse for studies on the metabolism of drugs: application to the metabolism of fentanyl and acetylfentanyl
Tatsuyuki Kanamori et al.
FORENSIC TOXICOLOGY (2018)
A long-term culture system based on a collagen vitrigel membrane chamber that supports liver-specific functions of hepatocytes isolated from mice with humanized livers
Ryuji Watari et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2018)
An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease
Javier De Las Heras et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology
Takuro Uchida et al.
JOURNAL OF GENERAL VIROLOGY (2017)
FETAL GENE THERAPY FOR ORNITHINE TRANSCARBAMYLASE DEFICIENCY BY INTRAHEPATIC PLASMID DNA-MICRO-BUBBLE INJECTION COMBINED WITH HEPATIC ULTRASOUND INSONATION
Yoshie Oishi et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2016)
Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD)
Alexander Laemmle et al.
PLOS ONE (2016)
Novel Robust in Vitro Hepatitis B Virus Infection Model Using Fresh Human Hepatocytes Isolated from Humanized Mice
Yuji Ishida et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation
Tatyana N. Tarasenko et al.
PLOS ONE (2015)
Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model
Beatrice Bissig-Choisat et al.
NATURE COMMUNICATIONS (2015)
Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice
Chise Tateno et al.
PLOS ONE (2015)
New potential cell source for hepatocyte transplantation: Discarded livers from metabolic disease liver transplants
Roberto Gramignoli et al.
STEM CELL RESEARCH (2013)
Prediction of In Vivo Hepatic Clearance and Half-Life of Drug Candidates in Human Using Chimeric Mice with Humanized Liver
Seigo Sanoh et al.
DRUG METABOLISM AND DISPOSITION (2012)
Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients
Juan C. Marini et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
In Vitro Evaluation of Cytochrome P450 and Glucuronidation Activities in Hepatocytes Isolated from Liver-Humanized Mice
Chihiro Yamasaki et al.
DRUG METABOLISM AND PHARMACOKINETICS (2010)
Biochemical data in ornithine transcarbamylase deficiency (OTCD) carrier risk estimation: logistic discrimination and combination with genetic information
K Oexle
JOURNAL OF HUMAN GENETICS (2006)
Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency
K Gyato et al.
ANNALS OF NEUROLOGY (2004)
How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency?
S Grunewald et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2004)
分享论文
